Montpellier, France

Sebastien Richeter

This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Nanomedsyn, Universitè De Montpellier. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sebastien Richeter. Retrieved from https://idiyas.com/inventor/sebastien-richeter

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Sebastien Richeter

Introduction

Sebastien Richeter is a notable inventor based in Montpellier, France. He has made significant contributions to the field of nanotechnology, particularly through his work on mesoporous organosilica nanoparticles. His innovative approach has implications for both medical treatment and imaging techniques.

Latest Patents

Richeter holds a patent for "Mesoporous organosilica nanoparticles, production method thereof and uses of same." This invention focuses on the preparation of mesoporous organosilica nanoparticles and their applications in photodynamic therapy and imaging. The patent highlights the potential of these nanoparticles in advancing therapeutic methods.

Career Highlights

Throughout his career, Richeter has been associated with prestigious institutions such as the Centre National de la Recherche Scientifique and Université de Montpellier. His work at these organizations has allowed him to explore and develop innovative solutions in his field.

Collaborations

Richeter has collaborated with notable colleagues, including Jean Olivier Durand and Jimenez Chiara Mauriello. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Sebastien Richeter's contributions to the field of nanotechnology, particularly through his patented work on mesoporous organosilica nanoparticles, demonstrate his innovative spirit and dedication to advancing medical applications. His career reflects a commitment to research and collaboration that continues to impact the scientific community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…